Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis
Dennis G. Moledina, … , Lloyd G. Cantley, Chirag R. Parikh
Dennis G. Moledina, … , Lloyd G. Cantley, Chirag R. Parikh
Published May 16, 2019
Citation Information: JCI Insight. 2019;4(10):e127456. https://doi.org/10.1172/jci.insight.127456.
View: Text | PDF
Clinical Research and Public Health Inflammation Nephrology

Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis

  • Text
  • PDF
Abstract

BACKGROUND Clinical diagnosis of acute interstitial nephritis (AIN) is challenging because of lack of a diagnostic biomarker and requires a kidney biopsy. We hypothesized that AIN is mediated by specific T cell subsets such that specific T cell cytokine levels could serve as biomarkers to distinguish AIN from other causes of acute kidney disease (AKD).METHODS We enrolled consecutive sampling participants who underwent a kidney biopsy for AKD evaluation at 2 centers between 2015 and 2018. Three pathologists independently established AIN diagnosis through review of kidney biopsies. Through univariable and multivariable analysis of 12 selected urine and plasma cytokines, we identified 2 that were diagnostic of AIN.RESULTS Of the 218 participants, 32 (15%) were diagnosed with AIN by all 3 pathologists. Participants with AIN had consistently higher levels of urine TNF-α and IL-9 than those with other diagnoses, including acute tubular injury, glomerular diseases, and diabetic kidney disease, and those without any kidney disease. As compared with participants in the lowest quartile, we noted higher odds of AIN in participants in the highest quartiles of TNF-α levels (adjusted odds ratio, 10.9 [1.8, 65.9]) and IL-9 levels (7.5 [1.2, 45.7]) when controlling for blood eosinophils, leukocyturia, and proteinuria. Addition of biomarkers improved area under receiver operating characteristic curve over clinicians’ prebiopsy diagnosis (0.84 [0.78, 0.91]) vs. 0.62 [(0.53, 0.71]) and a model of current tests (0.84 [0.76, 0.91] vs. 0.69 [0.58, 0.80]).CONCLUSIONS Inclusion of urinary TNF-α and IL-9 improves discrimination over clinicians’ prebiopsy diagnosis and currently available tests for AIN diagnosis.FUNDING Supported by NIH awards K23DK117065, T32DK007276, K24DK090203, K23DK097201, R01DK113191, UG3-DK114866, P30DK079310; the Robert E. Leet and Clara Guthrie Patterson Trust; and American Heart Association award 18CDA34060118.

Authors

Dennis G. Moledina, F. Perry Wilson, Jordan S. Pober, Mark A. Perazella, Nikhil Singh, Randy L. Luciano, Wassim Obeid, Haiqun Lin, Michael Kuperman, Gilbert W. Moeckel, Michael Kashgarian, Lloyd G. Cantley, Chirag R. Parikh

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 Total
Citations: 8 16 14 17 17 8 4 84
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (84)

Title and authors Publication Year
Adding Insult to Injury: The Spectrum of Tubulointerstitial Responses in Acute Kidney Injury
Megan L. Baker, Lloyd G. Cantley
Journal of Clinical Investigation 2025
Urine proteomics defines an immune checkpoint-associated nephritis signature
Long JP, Singh S, Dong Y, Yee C, Lin JS
Journal for Immunotherapy of Cancer 2025
Advances in the diagnosis of early biomarkers for acute kidney injury: a literature review
Yang H, Chen Y, He J, Li Y, Feng Y
BMC Nephrology 2025
Inflammatory markers mediate association of AIP with kidney failure risk: data from National Health and Nutrition Examination Survey (NHANES) 2005–2018
Guan C, Chen R, Wang Y
Renal Failure 2025
Acute Kidney Injury Associated with Novel Anticancer Therapies: Immunotherapy
Karam S, Ali A, Fung W, Mehta P, Nair S, Anandh U
Kidney360 2025
Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Single-Center Experience of Biopsy-Proven Cases
Kommer A, Stortz M, Kraus D, Weinmann-Menke J
Journal of Clinical Medicine 2025
Update on Acute Tubulointerstitial Nephritis: Clinical Features, Immunologic Insights, and Diagnostic and Treatment Approaches
Sahutoglu T, Perazella MA
Kidney International Reports 2025
Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis.
Gupta S, Mistry K, Alikhan FM, Mejia SM, Sadarangani S, Cao A, Wells SL, Koval E, Liang C, Ortega JL, Zubiri L, Sun J, Lawless AR, Peterkin AC, Kernin IJ, Best R, Otten TJ, Yamada KS, Obeid W, Sullivan R, Kluger H, Buchbinder EI, Reynolds KL, Villani AC, Parikh CR, Moledina DG, Sise ME
Kidney international 2025
Toward Precision Medicine: Exploring the Landscape of Biomarkers in Acute Kidney Injury.
Nourie N, Ghaleb R, Lefaucheur C, Louis K
Biomolecules 2024
The diagnosis of acute interstitial nephritis caused by infection versus antibiotic-induced interstitial nephritis: a narrative review
Muhammad A, Zhang Y, Huang L, Yuan Q, Wang W, Pu J, Lin W, Tang R, Xiao X
Clinical Kidney Journal 2024
The development of lateral flow devices for urinary biomarkers to assess kidney health
D Souza S, Obeid W, Hernandez J, Hu D, Wen Y, Moledina DG, Albert A, Gregg A, Wheeler A, Philbrook HT, Parikh CR
Scientific Reports 2024
Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis.
Barsotti GC, Luciano R, Kumar A, Meliambro K, Kakade V, Tokita J, Naik A, Fu J, Peck E, Pell J, Reghuvaran A, Tanvir EM, Patel P, Zhang W, Li F, Moeckel G, Perincheri S, Cantley L, Moledina DG, Wilson FP, He JC, Menon MC
Kidney International Reports 2024
Biomarkers in pursuit of precision medicine for acute kidney injury: hard to get rid of customs
Lin KM, Su CC, Chen JY, Pan SY, Chuang MH, Lin CJ, Wu CJ, Pan HC, Wu VC
Kidney Research and Clinical Practice 2024
The Road to Precision Medicine for Acute Kidney Injury
Birkelo BC, Koyner JL, Ostermann M, Bhatraju PK
Critical Care Medicine 2024
Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement.
Zarbock A, Forni LG, Koyner JL, Bell S, Reis T, Meersch M, Bagshaw SM, Fuhmann DY, Liu KD, Pannu N, Arikan AA, Angus DC, Duquette D, Goldstein SL, Hoste E, Joannidis M, Jongs N, Legrand M, Mehta RL, Murray PT, Nadim MK, Ostermann M, Prowle J, See EJ, Selby NM, Shaw AD, Srisawat N, Ronco C, Kellum JA
Intensive Care Medicine 2024
Urinary Biomarkers for Non-Invasive Diagnosis of Acute Interstitial Nephritis
Palanisamy T, Basu S, Srinivas BH, Shamanna S
Indian Journal of Nephrology 2024
Association of peripheral eosinophil count with chronic kidney disease progression risk: a retrospective cohort study in Chinese population
Ren Y, Zhang J, Hu X, Yu R, Tu Q, Li Y, Lin B, Zhu B, Shao L, Wang M
Renal Failure 2024
Baseline systemic inflammatory indices and clinicopathological features to predict the outcome of acute tubulointerstitial nephritis : A single-center retrospective study.
Dirim AB, Namazova N, Dirim MG, Oto OA, Artan AS, Hurdogan O, Ozluk Y, Yazici H
Wiener klinische Wochenschrift 2024
Biomarkers in acute kidney injury.
Ostermann M, Legrand M, Meersch M, Srisawat N, Zarbock A, Kellum JA
Annals of intensive care 2024
10 tips on how to use dynamic risk assessment and alerts for AKI
Quickfall D, La AM, Koyner JL
Clinical Kidney Journal 2024
Perioperative Acute Kidney Injury: Diagnosis, Prediction, Prevention, and Treatment
Douville NJ, Mathis M, Kheterpal S, Heung M, Schaub J, Naik A, Kretzler M
Anesthesiology 2024
Urinary RANTES and MCP-1 as noninvasive biomarkers for differential diagnosis and prediction of treatment response in acute interstitial nephritis
Baeg SI, Lee K, Jeon J, Lee JE, Kwon GY, Huh W, Jang HR
Clinical Kidney Journal 2024
Novel Biomarkers and Imaging Tests for Acute Kidney Injury Diagnosis in Patients with Cancer
Mistry K, Sadarangani S, Moreno D, Mejia SM, Moledina DG, Sise ME
Kidney360 2024
External Validation of an Electronic Health Record–Based Diagnostic Model for Histological Acute Tubulointerstitial Nephritis
Moledina DG, Shelton K, Menez S, Aklilu AM, Yamamoto Y, Kadhim BA, Shaw M, Kent C, Makhijani A, Hu D, Simonov M, O\u2019Connor K, Bitzel J, Thiessen-Philbrook H, Wilson FP, Parikh CR
Journal of the American Society of Nephrology : JASN 2024
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
Sise ME, Wang Q, Seethapathy H, Moreno D, Harden D, Smith RN, Rosales IA, Colvin RB, Chute S, Cornell LD, Herrmann SM, Fadden R, Sullivan RJ, Yang NJ, Barmettler S, Wells S, Gupta S, Villani AC, Reynolds KL, Farmer J
Journal for ImmunoTherapy of Cancer 2023
Identification and validation of urine CXCL-9 as a biomarker for diagnosis of acute interstitial nephritis
Dennis Moledina, Wassim Obeid, Rex Smith, Ivy Rosales, Meghan Sise, Gilbert Moeckel, Michael Kashgarian, Michael Kuperman, Kirk Campbell, Sean Lefferts, Kristin Meliambro, Markus Bitzer, Mark Perazella, Randy Luciano, Jordan Pober, Lloyd Cantley, Robert Colvin, Francis Wilson, Chirag R. Parikh
Journal of Clinical Investigation 2023
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine
Longhitano E, Muscolino P, Lo Re C, Ferrara SA, Cernaro V, Gembillo G, Tessitore D, Speranza D, Figura F, Santarpia M, Silvestris N, Santoro D, Franchina T
Cancers 2023
Urinary interleukins (IL)-6 and IL-10 in schoolchildren from an area with low prevalence of Schistosoma haematobium infections in coastal Kenya
Njaanake KH, Omondi J, Mwangi I, Jaoko WG, Anzala O
2023
Biomarkers in acute kidney injury: On the cusp of a new era?
Canney M, Clark EG, Hiremath S
Journal of Clinical Investigation 2023
Urinary TNF-α as a potential biomarker for chronic primary low back pain
Gevers-Montoro C, Puente-Tobares M, Monréal A, Conesa-Buendía FM, Piché M, Ortega-De Mues A
Frontiers in integrative neuroscience 2023
Genome-Wide Association Study in Acute Tubulointerstitial Nephritis
Zhou XJ, Su T, Xie J, Xie QH, Wang LZ, Hu Y, Chen G, Jia Y, Huang JW, Li G, Liu Y, Yu XJ, Nath SK, Tsoi LC, Patrick MT, Berthier CC, Liu G, Wang SX, Xu H, Chen N, Hao CM, Zhang H, Yang L
Journal of the American Society of Nephrology : JASN 2023
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
Miao J, Herrmann SM
Clinical Kidney Journal 2023
APOBEC-1 deletion enhances cisplatin-induced acute kidney injury.
Guo X, Blanc V, Davidson NO, Velazquez H, Chen TM, Moledina DG, Moeckel GW, Safirstein RL, Desir GV
Scientific Reports 2023
The renal damage and mechanisms relevant to antitumoral drugs
Tang J, Yang N, Pan S, Ren P, Chen M, Jin J, He Q, Zeng Y
Frontiers in Oncology 2023
Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI? CON
Coca SG
2023
Nephrotoxicity in the Age of Immune Checkpoint Inhibitors: Mechanisms, Diagnosis, and Management
Moturi K, Sharma H, Hashemi-Sadraei N
International journal of molecular sciences 2023
Immunological mechanisms underlying clinical phenotypes and noninvasive diagnosis of immune checkpoint inhibitor-induced kidney disease
Seethapathy H, Mistry K, Sise ME
Immunological Reviews 2023
Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI?: Commentary.
Siew ED
2023
Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.
Baker ML, Yamamoto Y, Perazella MA, Dizman N, Shirali AC, Hafez N, Weinstein J, Simonov M, Testani JM, Kluger HM, Cantley LG, Parikh CR, Wilson FP, Moledina DG
Journal for ImmunoTherapy of Cancer 2022
Urine testing to differentiate glomerular from tubulointerstitial diseases on kidney biopsy
Tran AC, Melchinger H, Weinstein J, Shaw M, Kent C, Perazella MA, Wilson FP, Parikh CR, Moledina DG
Practical Laboratory Medicine 2022
Kidney Biopsy in Patients with Cancer along the Last Decade: A Multicenter Study
Bolufer M, García-Carro C, Blasco M, Quintana LF, Shabaka A, Rabasco C, Draibe J, Merino A, Melero MR, Alonso F, Buxeda A, Batalha P, Visús MT, Soler MJ
Journal of Clinical Medicine 2022
Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?
Bermejo S, Bolufer M, Riveiro-Barciela M, Soler MJ
Frontiers in Medicine 2022
Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient
Birkelo BC, Pannu N, Siew ED
Clinical journal of the American Society of Nephrology : CJASN 2022
Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition
Xu L, Guo J, Moledina DG, Cantley LG
Nature Communications 2022
The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity
Moss EM, Perazella MA
Frontiers in Medicine 2022
Drug-Induced Acute Kidney Injury.
Perazella MA, Rosner MH
Clinical journal of the American Society of Nephrology : CJASN 2022
Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis.
Melchinger H, Calderon-Gutierrez F, Obeid W, Xu L, Shaw MM, Luciano RL, Kuperman M, Moeckel GW, Kashgarian M, Wilson FP, Parikh CR, Moledina DG
Clinical journal of the American Society of Nephrology : CJASN 2022
Exploring Urinary Extracellular Vesicles and Immune Mediators as Biomarkers of Kidney Injury in COVID-19 Hospitalized Patients
Medeiros T, Alves LS, Cabral-Castro MJ, Silva AR, Xavier AR, Burger D, Almeida JR, Silva AA
Diagnostics 2022
Biomarkers for Early Diagnosis of AKI: Could It Backfire?
Claure-Del Granado R, Macedo E, Chávez-Íñiguez JS
2022
Serum Uromodulin Is a Possible Auxiliary Diagnostic Tool for Acute Tubular Injury and Acute Interstitial Nephritis: A Case Series
Usui R, Ogawa T, Iwasaki C, Nitta K, Koike M
Case Reports in Nephrology and Dialysis 2022
Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data.
Moledina DG, Eadon MT, Calderon F, Yamamoto Y, Shaw M, Perazella MA, Simonov M, Luciano R, Schwantes-An TH, Moeckel G, Kashgarian M, Kuperman M, Obeid W, Cantley LG, Parikh CR, Wilson FP
Nephrology Dialysis Transplantation 2022
A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM
Lei R, Vu B, Kourentzi K, Soomro S, Danthanarayana AN, Brgoch J, Nadimpalli S, Petri M, Mohan C, Willson RC
Frontiers in immunology 2022
Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors
Farooqui N, Zaidi M, Vaughan L, McKee TD, Ahsan E, Pavelko KD, Villasboas JC, Markovic S, Taner T, Leung N, Dong H, Alexander MP, Herrmann SM
Kidney International Reports 2022
Definitions, phenotypes, and subphenotypes in acute kidney injury-Moving towards precision medicine.
Rodrigues CE, Endre ZH
Nephrology (Carlton, Vic.) 2022
Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge
Miao J, Sise ME, Herrmann SM
2022
Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis
JS Lin, O Mamlouk, U Selamet, A Tchakarov, WF Glass, RA Sheth, RM Layman, R Dadu, N Abdel-Wahab, M Abdelrahim, A Diab, C Yee, A Abudayyeh
OncoImmunology 2021
Close Association Between Altered Urine-urothelium Barrier and Tertiary Lymphoid Structure Formation in the Renal Pelvis During Nephritis
O Ichii, M Hosotani, A Masum, T Horino, T Nakamura, T Namba, Y Otani, Y Elewa, Y Kon
Journal of the American Society of Nephrology : JASN 2021
Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective
, Z Li, R Lin, J Shan, Q Yu, R Wang, L Liao, W Yan, Z Wang, L Shang, Y Huang, Q Zhang, K Xiong
Frontiers in Cell and Developmental Biology 2021
Tubulointerstitial nephritis and uveitis syndrome following meningitis and systemic lymphadenopathy with persistent Toxoplasma immunoglobulin M: a case report
Y Oya, H Futami, T Nakazawa, K Ishijima, K Umemiya, F Takizawa, N Imai, H Kitamura, R Matsumura
Journal of medical case reports 2021
Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese
X Zhou, LC Tsoi, Y Hu, MT Patrick, K He, CC Berthier, Y Li, Y Wang, Y Qi, Y Zhang, T Gan, Y Li, P Hou, L Liu, S Shi, J Lv, H Xu, H Zhang
Clinical journal of the American Society of Nephrology : CJASN 2021
Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19
S Menez, DG Moledina, H Thiessen-Philbrook, FP Wilson, W Obeid, M Simonov, Y Yamamoto, CP Corona-Villalobos, C Chang, BT Garibaldi, W Clarke, S Farhadian, CD Cruz, SG Coca, CR Parikh
American journal of kidney diseases : the official journal of the National Kidney Foundation 2021
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study
DG Moledina, M Simonov, Y Yamamoto, J Alausa, T Arora, A Biswas, LG Cantley, L Ghazi, JH Greenberg, M Hinchcliff, C Huang, SG Mansour, M Martin, A Peixoto, W Schulz, L Subair, JM Testani, U Ugwuowo, P Young, FP Wilson
American journal of kidney diseases : the official journal of the National Kidney Foundation 2021
Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor–Associated Adverse Events
B Adam, N Murakami, G Reid, K Du, R Jasim, C Boils, L Bu, P Hill, A Murray, K Renaudin, C Roufosse, A Weins, K Wen, L Riella, M Mengel
Clinical journal of the American Society of Nephrology : CJASN 2021
Ibrutinib-induced acute kidney injury via interstitial nephritis.
Markóth C, File I, Szász R, Bidiga L, Balla J, Mátyus J
Renal Failure 2021
The Challenges of Acute Interstitial Nephritis: Time to Standardize.
Moledina DG, Perazella MA
2021
Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations.
Perazella MA, Sprangers B
Clinical Kidney Journal 2021
The Promise of Tubule Biomarkers in Kidney Disease: A Review.
Ix JH, Shlipak MG
American journal of kidney diseases : the official journal of the National Kidney Foundation 2021
Urinary Cytokines Reflect Renal Inflammation in Acute Tubulointerstitial Nephritis: A Multiplex Bead-Based Assay Assessment.
Martinez Valenzuela L, Draibe J, Bestard O, Fulladosa X, Gómez-Preciado F, Antón P, Nadal E, Jové M, Cruzado JM, Torras J
Journal of Clinical Medicine 2021
Potential Value of TNF-α (-376 G/A) Polymorphism and Cystatin C (CysC) in the Diagnosis of Sepsis Associated Acute Kidney Injury (S-AK I) and Prediction of Mortality in Critically Ill patients.
Al-Amodi HS, Abdelsattar S, Kasemy ZA, Bedair HM, Elbarbary HS, Kamel HFM
Frontiers in Molecular Biosciences 2021
Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management.
Seethapathy H, Herrmann SM, Sise ME
2021
Urine interleukin-9 and tumor necrosis factor-α for prognosis of human acute interstitial nephritis.
Moledina DG, Wilson FP, Kukova L, Obeid W, Luciano R, Kuperman M, Moeckel GW, Kashgarian M, Perazella MA, Cantley LG, Parikh CR
Nephrology Dialysis Transplantation 2021
Urine Sediment Exam Provides More Diagnostic Information in AKI than Novel Urinary Biomarkers: PRO
Cavanaugh C
2021
Non-diabetic glycosuria as a diagnostic clue for acute tubulointerstitial nephritis in patients with azotemia
Lee T, Yang WS
Renal Failure 2020
Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: PRO.
Eijgelsheim M, Sprangers B
2020
Management of Drug-Associated Acute Interstitial Nephritis.
Barreto EF, Rule AD
2020
Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: Commentary.
Perazella MA
2020
AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI.
Liu KD, Goldstein SL, Vijayan A, Parikh CR, Kashani K, Okusa MD, Agarwal A, Cerdá J
Clinical journal of the American Society of Nephrology : CJASN 2020
New Biomarkers in Acute Tubulointerstitial Nephritis: A Novel Approach to a Classic Condition.
Martinez Valenzuela L, Draibe J, Fulladosa X, Torras J
International journal of molecular sciences 2020
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations.
Piscitani L, Sirolli V, Di Liberato L, Morroni M, Bonomini M
International journal of molecular sciences 2020
Eosinophilia and risk of incident end stage kidney disease
Tariq A, Okamato K, Tariq A, Rosenberg AZ, Soliman KM, Ploth DW, Atta MG, McMahon BA
BMC Nephrology 2020
Assessing the health of the nephron in acute kidney injury: biomarkers of kidney function and injury
S Menez, CR Parikh
Current Opinion in Nephrology and Hypertension 2019
Differentiating Acute Interstitial Nephritis from Acute Tubular Injury: A Challenge for Clinicians.
Moledina DG, Parikh CR
Nephron 2019
Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis.
Qualls D, Seethapathy H, Bates H, Tajmir S, Heidari P, Endres P, Reynolds K, Lawrence D, Sise M
Journal for ImmunoTherapy of Cancer 2019
Acute Kidney Injury with Immune Checkpoint Inhibitors: A Push beyond Case Reports
Carlos CA, Hsu RK
Clinical journal of the American Society of Nephrology : CJASN 2019

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts